DNTH vs ROP · rev $6.2M vs P/E 41, rev $1.88B
Dianthus Therapeutics Inc. (DNTH) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
DNTH currently screens at market cap $4.40B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the DNTH and ROP stock pages for the full models.
Not investment advice.